Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05169242

A Trial on Prophylactic Clipping to Prevent Post-polypectomy Bleeding After Colonoscopy in Direct Oral Anticoagulant Users

Led by Chinese University of Hong Kong · Updated on 2024-08-29

584

Participants Needed

1

Research Sites

158 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The investigators hypothesize that prophylactic clipping after colonoscopic polypectomy can reduce risk of delayed PPB among DOAC users. The investigators also hypothesize that pre-endoscopy drug level can predict the risk of hemorrhagic complications after the procedure.

CONDITIONS

Official Title

A Trial on Prophylactic Clipping to Prevent Post-polypectomy Bleeding After Colonoscopy in Direct Oral Anticoagulant Users

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Active users of any direct oral anticoagulant (DOAC)
  • Scheduled for elective colonoscopy for colorectal cancer screening, polyp surveillance, or investigation of symptoms like anemia or past gastrointestinal bleeding
  • At least 18 years old
  • Provided written informed consent
Not Eligible

You will not qualify if you...

  • Absolute contraindications to colonoscopy
  • Medical conditions preventing interruption of DOAC for the procedure
  • Medical conditions requiring uninterrupted dual antiplatelet therapy (single antiplatelet therapy allowed)
  • Active gastrointestinal bleeding
  • Clinically significant bleeding tendency such as decompensated cirrhosis or severe thrombocytopenia
  • Severe renal impairment with creatinine clearance less than 15 ml/min
  • Pregnancy or breastfeeding
  • Advanced comorbid conditions defined as American Society of Anesthesiologists grade 4 or above
  • Unable to provide informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Prince of Wales Hospital

Shatin, New Territories, Hong Kong

Actively Recruiting

Loading map...

Research Team

L

Louis Ho Shing Lau

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here